Meyi 2023: I-Omidubicel-onlv (Omisirge, Gamida Cell Ltd.) yagunyazwa yi-Food and Drug Administration ukuze isetshenziswe ezigulini ezikhulile nezezingane (ezineminyaka engu-12 ubudala nangaphezulu) ezinezifo ze-hematological ezihlelelwe ukuthola.